Literature DB >> 15105291

Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis.

Désirée Bonci1, Michael Hahne, Nadia Felli, Cesare Peschle, Ruggero De Maria.   

Abstract

A proliferation-inducing ligand (APRIL) is a new tumor necrosis factor family member implicated in tumor cell proliferation. We investigated the role of APRIL in megakaryocytopoiesis, a developmental hematopoietic process responsible for progenitor cell differentiation to megakaryoblasts and megakaryocytes, leading to platelet formation. APRIL is not expressed in CD34(+) progenitor cells from healthy donors, but it is massively up-regulated during the proliferative phase of megakaryocytic cell differentiation. Exogenous APRIL expression in primary cells increases megakaryocytic cell growth, suggesting that APRIL acts as a proliferative factor in megakaryocytopoiesis. More importantly, neutralization of endogenous APRIL was able to dramatically reduce megakaryocyte expansion and platelet production. Thus, our data provide evidence that APRIL acts as a growth factor for terminal megakaryocytopoiesis and may promote physiologic platelet production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105291     DOI: 10.1182/blood-2003-11-3861

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Higher platelet counts correlate to tumour progression and can be induced by intratumoural stroma in non-metastatic breast carcinomas.

Authors:  Natalia Bednarz-Knoll; Marta Popęda; Tomasz Kryczka; Barbara Kozakiewicz; Katarzyna Pogoda; Jolanta Szade; Aleksandra Markiewicz; Damian Strzemecki; Leszek Kalinowski; Jarosław Skokowski; Jian Liu; Anna J Żaczek
Journal:  Br J Cancer       Date:  2021-12-02       Impact factor: 7.640

2.  Aberrant Expression of a Proliferation-Inducing Ligand Underlies Autoimmune Mechanisms in Immune Thrombocytopenia.

Authors:  Y F Hao; H Bi; H Y Li; L M Yin; J X Yu; W Tao; H L Mu; R C Yang; Z P Zhou; W L Tai
Journal:  J Immunol Res       Date:  2021-01-30       Impact factor: 4.818

3.  A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia.

Authors:  Lukasz Bolkun; Marlena Tynecka; Tomasz Wasiluk; Jaroslaw Piszcz; Aleksandra Starosz; Kamil Grubczak; Marcin Moniuszko; Andrzej Eljaszewicz
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

4.  BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.

Authors:  L Bolkun; D Lemancewicz; E Jablonska; A Kulczynska; U Bolkun-Skornicka; J Kloczko; J Dzieciol
Journal:  Ann Hematol       Date:  2013-10-19       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.